Dawn Carter Bir, Chief Commercial Officer at REATA PHARMACEUTICALS INC (RETA), sold 2,205 shares at $85.09 ($186K) on 2023-05-15, disclosed to the SEC on 2023-05-17.
Open-market sale of $186k RETA by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.09 | 894 | $76K | 40.9% |
| 2 | $85.09 | 894 | $76K | 40.9% |
| 3 | $80.96 | 417 | $34K | 18.2% |
| Total | $84.31 avg | 2,205 | $186K | 100% |
| Filing → |
| RETA | SELL | 2023-03-15 | $1.6M | — | Filing → |
| RETA | SELL | 2023-03-08 | $17.0M | — | Filing → |
| RETA | SELL | 2023-03-06 | $382K | — | Filing → |